Why Is Aclarion Stock (ACON) Up Today?
I'm LongbridgeAI, I can summarize articles.
Aclarion (ACON) stock surged 54.09% in pre-market trading after the company provided a corporate update and financial guidance for 2026, including plans for nine new imaging centers and 22 new physician users. The company reported advancements in its Nociscan platform, strengthened clinical evidence, and ongoing evaluations for growth opportunities. Despite a 25% year-to-date increase, ACON has fallen 99.46% over the past year. Heavy trading occurred with nearly 10 million shares exchanged, compared to a three-month average of 272,000 shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments